4 completed. 4 Phase 1.
By phase and status
Follow Bioequivalance: new trials by email Literature Review of Bioequivalance trials Research Report on Bioequivalance
Trials (filtered) newest first · largest first
All 4 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
An Open-label, Randomized, Single-dose, Two-treatment, Four-period, Fully Replicate Crossover Bioequivalence Study in Healthy Female Adult Participants Under Fasting Conditions Comparing the Test Product, Prontogest Solution for IM Injection With the Reference Product, Progesterone Injection Progesterone IM of 100 mg - Bioequivalance, Post-menopause | Phase 1 | Completed | 26 | 2025-11-10 | 2026-03-27 |
Bioequivalence Study of Vortioxetine in 20 mg Coated Tablets in Healthy Subjects Under Fasting Conditions Reference, Test - Bioequivalance | Phase 1 | Completed | 20 | 2025-03-18 | 2026-06-03 |
Bioavailability of Trazodone Hydrochloride (New Polymer) vs. Trazodone Hydrochloride Contramid® at Steady-state. 150 mg trazodone hydrochloride, 300 mg trazodone hydrochloride - Bioavailability Heathy Volunteers, Bioavailability Study | Phase 1 | Completed | 64 | 2024-05-22 | 2025-09-03 |
Bioequivalence Study Assessing Iron Sucrose or Venofer® in Healthy Adult Subjects Iron Sucrose Injection, Venofer Injection - Bioequivalance | Phase 1 | Completed | 196 | 2019-09-19 | 2020-07-31 |
Interventions
Ferric Oxide, Saccharated (1) · Progesterone (1) · Trazodone (1)
Sponsors
ADIUM (1) · Aziende Chimiche Riunite Angelini Francesco S.p.A (1) · Baxter Healthcare Corporation (1) · Zi Diligence Biocenter (1)
Countries
Egypt (1) · Germany (1) · Mexico (1) · United States (1)
Top investigators
Amira Gouda, PhD Analytical Chemistry (1) · Eman Nouman, PhD, Analytical Chemistry (1) · Mohammed Abdulhafez, MBBCH (1) · Mostafa Salah, MSc, Pharmacology & Toxicology (1)
Results publications
PMID 42228061, PMID 42515774